John Paul Secrist - 17 Jun 2021 Form 3 Insider Report for Cyteir Therapeutics, Inc.

Role
Chief Scientific Officer
Signature
By: /s/ Andrew Gengos, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
17 Jun 2021
Net transactions value
$0
Form type
3
Filing time
17 Jun 2021, 21:16:51 UTC
Next filing
24 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CYT Stock Option (Right to Buy) 17 Jun 2021 Common Stock 55,151 $1.19 Direct F1
holding CYT Stock Option (Right to Buy) 17 Jun 2021 Common Stock 220,605 $1.19 Direct F2
holding CYT Stock Option (Right to Buy) 17 Jun 2021 Common Stock 102,927 $7.09 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 75% of the underlying shares of common stock on June 15, 2023, and as to the remaining shares underlying the award in 12 equal monthly installments thereafter, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.
F2 The option vested as to 25% of the underlying shares of common stock on June 15, 2021, and as to the remaining shares underlying the award in 36 equal monthly installments thereafter, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.
F3 The option vests as to 1/3rd of the underlying shares of common stock on February 5, 2022, the first anniversary of the of the vesting commencement date, and at a rate of 1/36th of the underlying shares of common stock at the end of each subsequent monthly anniversary of the vesting commencement date until the option is fully vested on the third anniversary of the vesting commencement date, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney